L. Callol

749 total citations
22 papers, 576 citations indexed

About

L. Callol is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Oncology. According to data from OpenAlex, L. Callol has authored 22 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Biomedical Engineering and 3 papers in Oncology. Recurrent topics in L. Callol's work include Advanced Chemical Sensor Technologies (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Pediatric health and respiratory diseases (3 papers). L. Callol is often cited by papers focused on Advanced Chemical Sensor Technologies (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Pediatric health and respiratory diseases (3 papers). L. Callol collaborates with scholars based in Spain and Colombia. L. Callol's co-authors include Javier Jareño, V G Villarrubia, Marcos Zuil, Santiago Coca, F Rojas Villegas, Alvarez-Sala Jl, Melchor Álvarez‐Mon, Rodolfo Álvarez-Sala, Marc Miravitlles and Jorge Monserrat and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Lung Cancer.

In The Last Decade

L. Callol

21 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Callol Spain 7 337 223 166 49 49 22 576
Javier Jareño Spain 5 301 0.9× 215 1.0× 132 0.8× 36 0.7× 42 0.9× 16 498
Chun‐Liang Chou Taiwan 12 262 0.8× 132 0.6× 120 0.7× 175 3.6× 76 1.6× 26 607
Frank Aboubakar Nana Belgium 14 61 0.2× 184 0.8× 171 1.0× 107 2.2× 32 0.7× 29 510
Jamal Zaini Indonesia 10 126 0.4× 89 0.4× 66 0.4× 60 1.2× 28 0.6× 38 329
MS Klempner United States 7 185 0.5× 51 0.2× 42 0.3× 72 1.5× 56 1.1× 8 366
Sangeetha Prabhakaran United States 8 195 0.6× 255 1.1× 65 0.4× 80 1.6× 11 0.2× 20 425
Trivikram Dasu United States 10 237 0.7× 38 0.2× 53 0.3× 85 1.7× 31 0.6× 13 489
Kristy Nichol Australia 12 162 0.5× 58 0.3× 175 1.1× 117 2.4× 126 2.6× 21 514
Danay Saavedra Cuba 10 164 0.5× 134 0.6× 52 0.3× 86 1.8× 33 0.7× 30 389
Ravisankar A. Ramadas United States 10 305 0.9× 47 0.2× 45 0.3× 94 1.9× 93 1.9× 13 453

Countries citing papers authored by L. Callol

Since Specialization
Citations

This map shows the geographic impact of L. Callol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Callol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Callol more than expected).

Fields of papers citing papers by L. Callol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Callol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Callol. The network helps show where L. Callol may publish in the future.

Co-authorship network of co-authors of L. Callol

This figure shows the co-authorship network connecting the top 25 collaborators of L. Callol. A scholar is included among the top collaborators of L. Callol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Callol. L. Callol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jareño, Javier, et al.. (2014). Volatile Organic Compounds (VOC) in Exhaled Breath in Patients With Lung Cancer. CHEST Journal. 145(3). 334A–334A. 2 indexed citations
3.
Jareño, Javier, et al.. (2012). Volatile Organic Compounds (VOC) in exhaled breath in patients with lung cancer (LC). Lung Cancer. 77. S31–S32. 3 indexed citations
4.
Jareño, Javier, María Ángeles Muñoz, Á. Rodríguez, et al.. (2011). New contributions in the determination of volatile organic compounds (VOC) in lung cancer (LC). 38. 2791. 1 indexed citations
5.
Miravitlles, Marc, Cristina Murio, Josep Morera, et al.. (2008). Efecto de AM3 en la calidad de vida de pacientes con enfermedad pulmonar obstructiva crónica en subgrupos de riesgo. Medicina Clínica. 130(18). 688–692. 3 indexed citations
6.
Callol, L., et al.. (2007). Low-dose CT: A useful and accessible tool for the early diagnosis of lung cancer in selected populations. Lung Cancer. 56(2). 217–221. 45 indexed citations
8.
Álvarez-Mon, Miguel Ángel, Marc Miravitlles, J. Morera, L. Callol, & Alvarez-Sala Jl. (2005). Treatment with the immunomodulator AM3 improves the health-related quality of life of patients with COPD. 1(2). 66–67. 5 indexed citations
9.
Álvarez‐Mon, Melchor, Marc Miravitlles, Josep Morera, L. Callol, & Alvarez-Sala Jl. (2005). Treatment With the Immunomodulator AM3 Improves the Health-Related Quality of Life of Patients With COPD. CHEST Journal. 127(4). 1212–1218. 30 indexed citations
10.
Álvarez-Sala, Rodolfo, et al.. (2004). How to express tumor markers in bronchoalveolar lavage. The International Journal of Biological Markers. 19(1). 67–71. 2 indexed citations
11.
González, Álvaro, et al.. (2002). Exactitud diagnóstica del análisis semicuantitativo de la tomografía por emisión de positrones en lesiones pulmonares radiológicamente indeterminadas. Revista Española de Medicina Nuclear. 21(6). 403–409. 4 indexed citations
12.
Villegas, F Rojas, Santiago Coca, V G Villarrubia, et al.. (2002). Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer. 35(1). 23–28. 349 indexed citations
13.
Prieto, Alfredo, Eduardo Reyes, Erica D. Bernstein, et al.. (2001). Defective Natural Killer and Phagocytic Activities in Chronic Obstructive Pulmonary Disease are Restored by Glycophosphopeptical (Inmunoferón). American Journal of Respiratory and Critical Care Medicine. 163(7). 1578–1583. 88 indexed citations
14.
Zuil, Marcos, et al.. (2001). Cryotherapy in the Diagnosis of Endobronchial Mucormycosis. Journal of Bronchology. 8(2). 107–109. 3 indexed citations
15.
Villegas, F Rojas, Marcos Zuil, José Pablo Díaz-Jiménez, et al.. (2001). Longstanding Intrabronchial Foreign Body in an Adult. Journal of Bronchology. 8(4). 289–293. 2 indexed citations
16.
Zuil, Marcos, et al.. (2001). Cryotherapy in the Diagnosis of Endobronchial Mucormycosis. Journal of Bronchology. 8(2). 107–109. 4 indexed citations
17.
Roig, Francisco J., et al.. (2001). Cavidad tuberculosa abscesificada de evolución tórpida por sobreinfección con Gemella haemolysans. Enfermedades Infecciosas y Microbiología Clínica. 19(10). 507–508. 3 indexed citations
19.
Álvarez-Sala, Rodolfo, et al.. (1995). [Cytologic and biochemical component in 203 bronchoalveolar lavages. Reference values].. PubMed. 12(1). 3–11. 1 indexed citations
20.
Álvarez-Sala, Rodolfo, et al.. (1989). Tumour Markers in Broncho-Alveolar Lavage. Acta Oncologica. 28(2). 290–291. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026